New patent expiration for Sarepta Theraps drug EXONDYS 51
Annual Drug Patent Expirations for EXONDYS+51 Exondys 51 is a drug marketed by Sarepta Theraps Inc and is included in […]
New patent expiration for Sarepta Theraps drug EXONDYS 51 Read Post »
Annual Drug Patent Expirations for EXONDYS+51 Exondys 51 is a drug marketed by Sarepta Theraps Inc and is included in […]
New patent expiration for Sarepta Theraps drug EXONDYS 51 Read Post »
Annual Drug Patent Expirations for VYONDYS+53 Vyondys 53 is a drug marketed by Sarepta Theraps Inc and is included in
New patent expiration for Sarepta Theraps drug VYONDYS 53 Read Post »
Annual Drug Patent Expirations for ATRIPLA Atripla is a drug marketed by Gilead Sciences and is included in one NDA.
New patent expiration for Gilead Sciences drug ATRIPLA Read Post »
Annual Drug Patent Expirations for EMTRIVA Emtriva is a drug marketed by Gilead and is included in two NDAs. It
Annual Drug Patent Expirations for AMONDYS+45 Amondys 45 is a drug marketed by Sarepta Theraps Inc and is included in
New patent expiration for Sarepta Theraps drug AMONDYS 45 Read Post »
Annual Drug Patent Expirations for VIBATIV Vibativ is a drug marketed by Cumberland Pharms and is included in one NDA.
New patent expiration for Cumberland Pharms drug VIBATIV Read Post »
VIBATIV (telavancin hydrochloride) Cumberland pharms Patent: 7,544,364 Expiration: May 1, 2021 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of April 25, 2021 Read Post »
Annual Drug Patent Expirations for ZYDELIG Zydelig is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug ZYDELIG Read Post »
Annual Drug Patent Expirations for OPTISON Optison is a drug marketed by Ge Healthcare and is included in one NDA.
New patent expiration for Ge Healthcare drug OPTISON Read Post »
Get fresh news and insights, drug patent expirations & more…